Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.
作者信息
Preece P E, Wood R A, Mackie C R, Cuschieri A
出版信息
Br Med J (Clin Res Ed). 1982 Mar 20;284(6319):869-70. doi: 10.1136/bmj.284.6319.869-a.
Abstract
摘要
相似文献
1
Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.他莫昔芬作为老年女性局部乳腺癌的初始单一治疗：一项试点研究。
Br Med J (Clin Res Ed). 1982 Mar 20;284(6319):869-70. doi: 10.1136/bmj.284.6319.869-a.
2
The value of high dose tamoxifen in postmenopausal breast cancer patients progressing on standard doses: a pilot study.高剂量他莫昔芬对标准剂量治疗后病情进展的绝经后乳腺癌患者的价值：一项初步研究。
Br J Cancer. 1988 Mar;57(3):320-1. doi: 10.1038/bjc.1988.72.
3
A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer-final results at 20-year follow-up.仅行乳房切除术与他莫昔芬治疗可手术原发性老年乳腺癌患者的随机试验：20 年随访的最终结果。
Crit Rev Oncol Hematol. 2011 Jun;78(3):260-4. doi: 10.1016/j.critrevonc.2010.04.006. Epub 2010 May 5.
4
Primary treatment of breast cancer in elderly women with Tamoxifen.他莫昔芬用于老年女性乳腺癌的初始治疗。
Clin Oncol. 1983 Mar;9(1):31-4.
5
[Tamoxifen as initial treatment in breast cancer in elderly women: a 10-year follow-up].[他莫昔芬作为老年女性乳腺癌的初始治疗：10年随访]
Rev Med Liege. 1990 Nov;45(11):533-8.
6
Ovarian volume in postmenopausal breast cancer patients treated with tamoxifen.接受他莫昔芬治疗的绝经后乳腺癌患者的卵巢体积
Gynecol Oncol. 1997 Jan;64(1):105-8. doi: 10.1006/gyno.1996.4512.
7
A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity.一项初步研究，旨在建立一种临床模型，用于对高危女性进行乳腺癌化学预防药物的II期研究，以生物标志物作为活性的替代终点。
Clin Cancer Res. 2004 Dec 15;10(24):8332-40. doi: 10.1158/1078-0432.CCR-04-0297.
8
[Adjuvant endocrine therapy of breast cancer].[乳腺癌的辅助内分泌治疗]
ZFA (Stuttgart). 1983 Apr 10;59(10):571-4.
9
Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer.使用加巴喷丁治疗乳腺癌女性他莫昔芬引起的潮热的初步研究。
Breast Cancer Res Treat. 2004 Jan;83(1):87-9. doi: 10.1023/B:BREA.0000010676.54597.22.
10
Clinical response to primary letrozole therapy in elderly patients with early breast cancer: possible role for p53 as a biomarker.老年早期乳腺癌患者应用来曲唑一线治疗的临床反应：p53 作为生物标志物的可能作用。
Int J Surg. 2014;12(8):821-6. doi: 10.1016/j.ijsu.2014.06.009. Epub 2014 Jul 8.
引用本文的文献
1
Differential Effects of Endocrine Therapy Type on Quality of Life in Older (≥70 Years) Women with Early-Stage Breast Cancer.内分泌治疗类型对老年（≥70岁）早期乳腺癌女性生活质量的不同影响。
Ann Surg Oncol. 2025 Apr 26. doi: 10.1245/s10434-024-16482-4.
2
Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus).老年女性（70岁及以上）可手术原发性乳腺癌的手术治疗与原发性内分泌治疗对比
Cochrane Database Syst Rev. 2014 May 19;5(5):CD004272. doi: 10.1002/14651858.CD004272.pub3.
3
The Present and Future of Neoadjuvant Endocrine Therapy for Breast Cancer Treatment.乳腺癌治疗中新辅助内分泌治疗的现状与未来
Cancers (Basel). 2021 May 21;13(11):2538. doi: 10.3390/cancers13112538.
4
Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes.跨越乳腺癌的年龄差距：在雌激素受体阳性早期乳腺癌老年女性中省略乳腺癌手术对生活质量结局的影响。
Br J Surg. 2021 Apr 5;108(3):315-325. doi: 10.1093/bjs/znaa125.
5
Protocol for a Systematic Review Assessing Surgery versus Primary Endocrine Therapy in Operable Breast Cancer. Prep for Pandemic.评估可手术乳腺癌手术与原发性内分泌治疗的系统评价方案。为大流行做准备。
Int J Surg Protoc. 2020 Nov 5;24:36-38. doi: 10.1016/j.isjp.2020.10.003. eCollection 2020.
6
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives.新辅助内分泌治疗在乳腺癌中的应用：现状与展望。
Int J Mol Sci. 2020 May 16;21(10):3528. doi: 10.3390/ijms21103528.
7
Neoadjuvant endocrine therapy in breast cancer patients.乳腺癌患者的新辅助内分泌治疗
Porto Biomed J. 2017 Sep-Oct;2(5):170-173. doi: 10.1016/j.pbj.2017.03.007. Epub 2017 May 2.
8
The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis.接受不同类型新辅助治疗的绝经后激素受体阳性乳腺癌的肿瘤反应：一项荟萃分析。
BMC Womens Health. 2020 Jan 31;20(1):17. doi: 10.1186/s12905-020-0879-y.
9
Current Status of Neoadjuvant Endocrine Therapy in Early Stage Breast Cancer.早期乳腺癌新辅助内分泌治疗的现状。
Curr Treat Options Oncol. 2018 Apr 16;19(5):23. doi: 10.1007/s11864-018-0538-9.
10
Preoperative Endocrine Therapy.术前内分泌治疗
Curr Breast Cancer Rep. 2017;9(4):202-209. doi: 10.1007/s12609-017-0255-6. Epub 2017 Oct 27.
本文引用的文献
1
The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions.他莫昔芬在平衡和非平衡条件下与雌激素受体蛋白的结合。
Eur J Cancer (1965). 1979 Mar;15(3):317-29. doi: 10.1016/0014-2964(79)90043-4.
2
Tamoxifen in advanced breast cancer.他莫昔芬用于晚期乳腺癌
Cancer Treat Rev. 1978 Sep;5(3):131-41. doi: 10.1016/s0305-7372(78)80017-6.
3
Hormonal therapy of breast cancer: new approaches and concepts.乳腺癌的激素治疗：新方法与新理念。
Ann Intern Med. 1978 Jan;88(1):69-77. doi: 10.7326/0003-4819-88-1-69.
4
The treatment of operable breast cancer in the elderly female.老年女性可手术乳腺癌的治疗
Am J Surg. 1978 May;135(5):664-6. doi: 10.1016/0002-9610(78)90131-9.
Zotero 插件